Artificial Intelligence | Machine Learning | Natural Language Processing Gero | AI-Driven Drug Discovery and Drug Repurposing

Enterprise, Pharmaceuticals, Biotechnology, Drug Development, Digital Health, Target Identification Singapore, Central Region, Singapore

Gero

Artificial Intelligence | Machine Learning | Natural Language Processing

Gero | AI-Driven Drug Discovery and Drug Repurposing

Gero

Pharmaceuticals, Biotechnology, Drug Development, Digital Health, Target Identification

Singapore, Central Region, Singapore

 

Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Our goal is to extend healthy lifespan dramatically and delay age-related health issues.

We identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models.

 
 

   Total Funding: $2,200,000

   Funding Stage: Series A

   Business Stage: N/A

   Market: N/A

   Company Size: 26 to 50

   Founded: 2015

 
 

For AI Startup Founders

Get introduced to VC/PE/CVC investors

Get Started

For Investors at VC/PE firms

Get introduced to AI Startup founders or founders at Gero

 
 
 
Maxim Kholin


Maxim Kholin
Co-Founder

Yuri Deigin


Yuri Deigin
COO

Sergei Filonov


Sergei Filonov
Co-founder and Chief Visionary Officer

 
 

Gero - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups appengine.ai Gero - Manage Profile

 
 
 
appengine.ai

World's Most Promising AI Startups


Pony.ai
Observe.AI
Kodiak Robotics
OpenAI
Abnormal Security
Groq
Cohere
Anthropic



World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals


Get Started